ETV4 Improves Cerebral Ischemia‐Reperfusion Injury by Restraining YBX1‐GPX4‐Ferroptosis Cascades
Brain and Behavior · 2026-06 · 16 (6)
DOI: 10.1002/brb3.71548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 16.06.2026. Verfasst von Qian Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, Hainan, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Ferroptosis, Phospholipid Hydroperoxide Glutathione Peroxidase, Brain Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cerebral ischemia‐reperfusion injury (CIRI) is a critical pathological process following ischemic stroke, with ferroptosis being increasingly recognized as a key contributor to neuronal damage. However, the regulatory mechanisms, particularly the role of specific transcription factors like E26 transformation‐specific variant 4 (ETV4), remain poorly understood. This study aimed to investigate the function and underlying mechanism of ETV4 in neuronal ferroptosis during CIRI.
Methods
In vitro, SH‐SY5Y cells subjected to oxygen‐glucose deprivation/reoxygenation (OGD/R) were used to model CIRI. Cell viability and ferroptosis markers (Fe 2 + , malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), reactive oxygen species (ROS)) were assessed. Molecular expressions were measured by Real‐time Quantitative PCR (RT‐qPCR) and/or western blot. In vivo, a rat model of middle cerebral artery occlusion/reperfusion (MCAO/R) was established, and brain injury was evaluated via 2% solution of 2,3,5‐triphenyl tetrazolium chloride (TTC), hematoxylin‐eosin (HE), and TdT‐mediated dUTP nick‐end labeling (TUNEL) staining. Chromatin immunoprecipitation (ChIP), dual‐luciferase reporter, RNA pull‐down, RNA immunoprecipitation (RIP), and actinomycin D assays were employed to validate the molecular interactions within the ETV4/Y‐box binding protein 1 (YBX1)/glutathione peroxidase‐4 (GPX4) axis.
Results
ETV4 was significantly down regulated in both the MCAO/R model and OGD/R‐treated cells. Overexpression of ETV4 markedly attenuated OGD/R‐induced oxidative stress, ferroptosis in vitro, and ameliorated brain injury in vivo. Mechanistically, ETV4 transcriptionally activated YBX1 by directly binding to its promoter. YBX1, in turn, stabilized GPX4 mRNA, which was modified by NSUN2‐mediated methylation. Crucially, the protective effects of ETV4 in vitro were abolished upon YBX1 or GPX4 knockdown.
Conclusion
Our findings demonstrate that ETV4 transcriptionally up regulates YBX1 to stabilize GPX4 mRNA in an NSUN2–m5Cmethylation dependent manner, thus suppressing neuronal ferroptosis. This reveals a novel ETV4/YBX1/GPX4 axis as a potential therapeutic target for CIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, Hainan, China.
- Department of Emergency, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
- Department of Dermatology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, Hainan, China.
Zitieren
APA
Xu, Q., Deng, F., & Yu, D. (2026). ETV4 Improves Cerebral Ischemia‐Reperfusion Injury by Restraining YBX1‐GPX4‐Ferroptosis Cascades. Brain and Behavior, 16(6). https://doi.org/10.1002/brb3.71548
Vancouver
Xu Q, Deng F, Yu D. ETV4 Improves Cerebral Ischemia‐Reperfusion Injury by Restraining YBX1‐GPX4‐Ferroptosis Cascades. Brain and Behavior. 2026;16(6). doi:10.1002/brb3.71548
BibTeX
@article{Xu2026,
author = {Xu, Qian and Deng, Faming and Yu, Dan},
title = {ETV4 Improves Cerebral Ischemia‐Reperfusion Injury by Restraining YBX1‐GPX4‐Ferroptosis Cascades},
journal = {Brain and Behavior},
year = {2026},
volume = {16},
number = {6},
doi = {10.1002/brb3.71548}
}
EUVIMED